Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
2.250
+0.060 (2.74%)
Oct 8, 2026, 12:40 PM EDT - Market open
Valion Bio Employees
Valion Bio had 52 employees as of December 31, 2025. The number of employees increased by 45 or 642.86% compared to the previous year. That makes Valion Bio the 34,700th largest employer in the world and 4,655th in the United States.
Employees
52
Change (1Y)
45
Growth (1Y)
642.86%
Revenue / Employee
n/a
Profits / Employee
-$369,808
Market Cap
2.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 52 | 45 | 642.86% |
| Dec 31, 2024 | 7 | -2 | -22.22% |
| Dec 31, 2023 | 9 | -7 | -43.75% |
| Jun 30, 2023 | 11 | - | - |
| Dec 31, 2022 | 16 | 9 | 128.57% |
| Dec 31, 2021 | 7 | -1 | -12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| PMGC Holdings | 34 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Genprex | 13 |
| Artelo Biosciences | 7 |
| Oragenics | 3 |
| Silo Pharma | 3 |
VBIO News
- 4 hours ago - Valion Bio Registration statement: Registration filing - Filings
- 6 hours ago - Valion Bio files $100M mixed securities shelf - TheFly
- 3 days ago - Valion Bio outlines perspectives of new Board Chair Jensen - TheFly
- 3 days ago - New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod - Accesswire
- 6 days ago - Valion Bio Proxy statement: Proxy filing - Filings
- 8 days ago - Valion Bio, Shear Kershman formulate oral mucosal entolimod - TheFly
- 8 days ago - Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity - Accesswire
- 15 days ago - Valion Bio appoints Dean Zikria as interim CEO, Thomas Jensen as chair - TheFly